Category: Pharmaceutical company
Industry: Drug Manufacturers - Major Quick infos Headquarters: Basel, Switzerland Trade prices Volume: 2.0M Market Cap: 186.65B Prev closed: 79.74 Open: 77.54 High: 81.04 Low: 77.16 52 week low: 69.18 52 week high: 99.84 Dividends: Next ER: April 25, 2023 Before Market Opens
About the Company Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales.
Earnings History Date EPS / Forecast Revenue / Forecast July 18, 2023 April 25, 2023 1.71 / 1.5312.95B / 12.75BBeat! February 1, 2023 1.52 / 1.4212.69B / 13.22BOctober 25, 2022 1.58 / 1.5512.5B / 12.88BJuly 19, 2022 1.56 / 1.5112.78B / 12.88Bview more
NYSE - New York Stock Exchange
More profiles and info about the company News
Novartis trades higher as Entresto, new drugs drive Q1 revenue, raises FY23 outlook seekingalpha.com Apr 25, 2023 4:58 pm Novartis beats Q1 top and bottom line estimates; raises FY23 outlook & planned spin-off on track for H2 seekingalpha.com Apr 25, 2023 1:05 pm Novartis hits 52-week high as Wall Street awaits Q1 2023 earnings seekingalpha.com Apr 25, 2023 12:22 am
U.S. Supreme Court rebuffs Novartis, allows generic versions of MS drug finance.yahoo.com Jan 27, 2023 5:12 pm
ImmunoGen (IMGN) Q3 Loss Wider, Sales Beat, '22 View Up finance.yahoo.com Jan 27, 2023 2:07 pm
UPDATE 1-U.S. FDA approves TG Therapeutics' multiple sclerosis drug finance.yahoo.com Jan 27, 2023 1:23 pm What is behind biotech M&A resurgence? seekingalpha.com Apr 24, 2023 Earnings Week Ahead: Amazon, Meta Platforms, Alphabet, Coca-Cola, Boeing, and more seekingalpha.com Apr 22, 2023 1:30 am Novartis, BeiGene tislelizumab meets main goal in gastric/esophagus cancer trial seekingalpha.com Apr 20, 2023 8:10 pm Novartis Kesimpta shows benefit in multiple sclerosis patients in 5-year data seekingalpha.com Apr 20, 2023 6:31 pm Amgen wins appeals court ruling in patent dispute over psoriasis drug Otezla seekingalpha.com Apr 20, 2023 4:16 am TG Therapeutics extends rally to hit 52-week high after B. Riley comments seekingalpha.com Apr 11, 2023 10:41 pm Novartis Humira biosimilar's high concentration gets approval in EU seekingalpha.com Apr 4, 2023 4:35 pm Novartis' heart drug Entresto gets EMA nod for expanded use in children seekingalpha.com Mar 31, 2023 9:24 pm Viatris, Aurobindo, Cipla to make generics of ViiV's HIV drug for low income countries seekingalpha.com Mar 30, 2023 5:13 pm Bicycle stock pops on cancer drug discovery pact with Novartis, gets $50M upfront seekingalpha.com Mar 28, 2023 7:27 pm Why did Novartis stock go up today? Early breast cancer trial results seekingalpha.com Mar 28, 2023 5:07 am Novartis upgraded to hold at Deutsche Bank following breast cancer drug results seekingalpha.com Mar 28, 2023 3:26 am Hot Stocks: ROKU and PINS rises on analyst upgrade; CAT stock and FYBR falls on downgrade; NVS higher on cancer trial success seekingalpha.com Mar 27, 2023 11:49 pm Novartis stock jumps on cancer trial success seekingalpha.com Mar 27, 2023 5:46 pm NVS Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Mar 9, 2023 2.2550848 Mar 20, 2023 Mar 8, 2022 2.1614124 Mar 17, 2022 Mar 4, 2021 2.0794 Mar 15, 2021 Mar 3, 2020 3.0425 Mar 12, 2020 Apr 9, 2019 2.8341 Apr 8, 2019 view more
Key Persons CEO : Vasant Narasimhan (1 Feb 2018–) Talk about Novartis ADR below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology
